Table 3.
Variable | Infrequent (n = 69) | Intermittent (n = 37) | Persistent (n = 7) | P Value |
Pulmonary function tests | ||||
FVC | 68.11 (13.59) | 67.1 (12.29) | 69.76 (9.13) | .76 |
Total lung capacity | 70.1 (12.01) | 69.99 (13.51) | 65.23 (12.34) | .62 |
Diffusing capacity of the lung for carbon monoxide | 47.36 (13.18) | 43.58 (13.42) | 41.18 (10.56) | .11 |
Health perception | ||||
Physical component summary | 31.48 (10.51) | 31.8 (10.63) | 30.56 (9.38) | .89 |
Mental component summary | 49.75 (9.8) | 49.38 (11.71) | 50.4 (6.4) | .94 |
Baseline dyspnea index | 5.86 (1.72) | 5.95 (1.72) | 6.43 (2.07) | .12 |
Health Assessment Questionnaire | 0.84 (0.65) | 0.89 (0.82) | 0.82 (0.62) | |
High-resolution CT scan | ||||
Maximal fibrosis | 1.91 (1.01) | 2.3 (0.91) | 3 (0.89) | .01 |
MaxGG | 0.68 (0.75) | 0.57 (0.8) | 1.33 (1.03) | .97 |
Maximal honeycomb score | 35 | 41 | 50 | .46 |
BAL | ||||
PMN | 6.05 (6.06) | 6.45 (6.22) | 14.87 (17.23) | .27 |
Eos | 2.95 (3.55) | 2.46 (4.85) | 2.1 (1.69) | .42 |
Clinical | ||||
Rodnan | 14.91 (9.81) | 12.16 (11.45) | 10 (11.96) | .01 |
Diffuse | 64 | 38 | 43 | .01 |
Gastroesophageal reflux disease | 58 | 38 | 100 | .68 |
Proton pump inhibitor use | 49 | 57 | 43 | .68 |
Pulmonary function tests are presented as % predicted (SD), and clinical scores (except Rodnan) are presented as %. See Table 1 legend for expansion of abbreviations.